{"id":172285,"date":"2025-11-10T08:04:05","date_gmt":"2025-11-10T13:04:05","guid":{"rendered":"https:\/\/44.250.171.167\/?p=172285"},"modified":"2025-11-10T08:04:05","modified_gmt":"2025-11-10T13:04:05","slug":"divis-laboratories-q2-fy26-earnings-results","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/divis-laboratories-q2-fy26-earnings-results\/","title":{"rendered":"Divis Laboratories Q2 FY26 Earnings Results"},"content":{"rendered":"<p>Divis Laboratories Ltd, a leading manufacturer and exporter of APIs, intermediates, and nutraceutical ingredients, reported strong financial results for Q2FY26.<\/p>\n<h2>Financial Highlights:<\/h2>\n<ul>\n<li>Revenues increased 16.12% year on year to \u20b92,715 crore from \u20b92,338 crore.<\/li>\n<li>Total expenses went up 13.12% to \u20b91,948 crore from \u20b91,722 crore.<\/li>\n<li>Consolidated net <a href=\"https:\/\/www.bseindia.com\/stock-share-price\/divis-laboratories-ltd\/divislab\/532488\/corp-announcements\/\" target=\"_blank\" rel=\"noopener\">profit<\/a> surged 35.1% to \u20b9689 crore from \u20b9510 crore.<\/li>\n<li>Earnings per share grew 35.09% to \u20b925.95 from \u20b919.21.<\/li>\n<\/ul>\n<p>The company\u2019s significant profit growth was driven by strong demand across global markets, operational efficiencies, and cost control initiatives. Divis also benefited from margin expansion amid competitive pressures in the pharmaceutical ingredients market.<\/p>\n<h2>Outlook:<\/h2>\n<p>Divis Laboratories is well positioned for continued growth with a robust order book, capacity expansions, and focused R&amp;D investments. The Q2FY26 results reinforce the company\u2019s leadership in the pharmaceutical ingredients space and its strategy for sustainable long-term value creation.<\/p>\n<p>Explore the company\u2019s past earnings and latest concall transcripts, <a href=\"https:\/\/44.250.171.167\/symbol\/divislab\/\">click here<\/a> to visit the AlphaStreet India News Channel.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-172286\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/D.png\" alt=\"Q2 FY26\" width=\"1489\" height=\"1817\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/D.png 1489w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/D-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/D-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/D-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/D-1259x1536.png 1259w\" sizes=\"auto, (max-width: 1489px) 100vw, 1489px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Divis Laboratories Ltd, a leading manufacturer and exporter of APIs, intermediates, and nutraceutical ingredients, reported strong financial results for Q2FY26. Financial Highlights: Revenues increased 16.12% year on year to \u20b92,715 crore from \u20b92,338 crore. Total expenses went up 13.12% to \u20b91,948 crore from \u20b91,722 crore. Consolidated net profit surged 35.1% to \u20b9689 crore from \u20b9510 [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":172286,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[12642],"class_list":["post-172285","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-nutraceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/D.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":168415,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q4fy25-23-rise-in-profits\/","url_meta":{"origin":172285,"position":0},"title":"Divis Laboratories Ltd Q4FY25; 23% rise in Profits","author":"Divyansh_Kasana","date":"May 19, 2025","format":false,"excerpt":"\u00a0 Company Overview: Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients. Financial Results: Divis Laboratories reported Total revenue for Q4FY25 of \u20b9 2,671 Crore up from \u20b92,382 Crore in Q4FY24, a rise of 12% y-o-y. Total Expense for Q4FY25 of \u20b91,807 Crore up from\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/616f6f02-c53b-426e-a315-5001b9f0b994.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/616f6f02-c53b-426e-a315-5001b9f0b994.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/616f6f02-c53b-426e-a315-5001b9f0b994.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/616f6f02-c53b-426e-a315-5001b9f0b994.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/616f6f02-c53b-426e-a315-5001b9f0b994.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/616f6f02-c53b-426e-a315-5001b9f0b994.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":147292,"url":"https:\/\/alphastreet.com\/india\/earnings-divis-laboratories-ltd-nse-divislab-q4fy23-results-out-total-income-fell-21-yoy\/","url_meta":{"origin":172285,"position":1},"title":"Earnings | Divis Laboratories Ltd (NSE: DIVISLAB): Q4FY23 Results Out; Total Income fell 21% YoY.","author":"Divyansh_Kasana","date":"May 25, 2023","format":false,"excerpt":"Divis Laboratories Ltd is a renowned Indian company specializing in the production and global export of Active Pharmaceutical Ingredients (APIs), Intermediates, and Nutraceutical ingredients. With a solid reputation in the pharmaceutical industry, the company has established itself as a leading manufacturer of high-quality chemicals. Divis Laboratories focuses on research, development,\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166064,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q2fy25-47-rise-in-profits\/","url_meta":{"origin":172285,"position":2},"title":"Divis Laboratories Ltd Q2FY25; 47% rise in Profits","author":"Divyansh_Kasana","date":"December 16, 2024","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for Q2FY25 of \u20b92,338.00 Crores up from \u20b91,909.00 Crore year on year, a rise of 22.47%. Total Expenses for Q2FY25 of \u20b91,722.00 Crores up from \u20b91,526.00 Crores year on\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/UU.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":169024,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q4fy25-23-rise-in-profits-2\/","url_meta":{"origin":172285,"position":3},"title":"Divis Laboratories Ltd Q4FY25; 23% rise in Profits","author":"Divyansh_Kasana","date":"July 7, 2025","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for Q4FY25 of \u20b92,585.00 Crores up from \u20b92,303.00 Crore year on year, a rise of 12.24%. Total Expenses for Q4FY25 of \u20b91,807.00 Crores up from \u20b91,669.00 Crores year on\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167573,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q3fy25-65-rise-in-profits\/","url_meta":{"origin":172285,"position":4},"title":"Divis Laboratories Ltd Q3FY25; 65% rise in Profits","author":"Divyansh_Kasana","date":"March 26, 2025","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for Q3FY25 of \u20b92,319.00 Crores up from \u20b91,855.00 Crore year on year, a rise of 25.01%. Total Expenses for Q3FY25 of \u20b91,675.00 Crores up from \u20b91,461.00 Crores year on\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":164227,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q1fy25-21-rise-in-profits\/","url_meta":{"origin":172285,"position":5},"title":"Divis Laboratories Ltd Q1FY25; 21% rise in Profits","author":"Divyansh_Kasana","date":"September 4, 2024","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for Q1FY25 of \u20b92,118.00 Crores up from \u20b91,778.00 Crore year on year, a rise of 19.12%. Total Expenses for Q1FY25 of \u20b91,593.00 Crores up from \u20b91,367.00 Crores year on\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/172285","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=172285"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/172285\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/172286"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=172285"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=172285"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=172285"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}